Ann: New Health Sensor Patent Applications Covering Gaming, Computer Devices, and Other Electronic Hardware, page-108

We shouldn't be worried about the slight weakness in the share price. It will drift backwards without concrete news of imminent success in the wearables market, which hopefully is coming in the next 6 months. Also, some shareholders partaking in the share options purchase in Nov might be dribbling CDX shares onto the market to raise cash to pay for these options in Nov. I have used the current share price weakness to keep accumulating stock as I think it is a real bargain under 7c, even with the current news we have. My only slight concern about the execution of the CDX wearables strategy is how robust their finding is they have effective equivalence to the Atcor sensor technology, which when proven will guarantee we are going to be really in the money with a massive revaluation of our share price. We await the news over the coming months that will confirm this. The ultimate validation will come first with hopefully FDA approval for CONNEQT Pulse as a standard and central blood pressure monitoring device. The problem with sitting on the side-lines and waiting for this news is the share price will be much higher than 7c, when this happens. We are also not sure when Mobvoi will launch their watch with CDX technology. This will also cause a re-rate of the share price. In the meantime I am very encouraged to see the news of the appointment of Gordan Lau as he has deep technical experience leading cutting edge technology teams at a prestigious research laboratory. For him to leave that environment and take on this leadership role within Cardiex he must have seen technology and data sets that will have convinced him this CONNEQT technology will succeed. For me this appointment de-risks the CONNEQT product development strategy while we wait for more concrete evidence we have a new technology with substantial equivalence to the AtCor gold standard for measuring central blood pressure. I have no doubt about the ability, ambition and commitment of Coops and his senior team to make a huge success of this opportunity once the technology is demonstrated and agree he has assembled a team, alongside the AtCor team, that does not look like a company with a market cap of 65 million. He has prepared a company structure for the rapid expansion phase coming. The next 12 months should be hugely rewarding as these building blocks fall into place.